Aurobindo Pharma Q3 Results
- BSE: 524804
- NSE: AUROPHARMA
- ISIN: INE406A01037
- Sector: Major Drugs
BSE
1,236.35
12.70 (1.04%)
12.70 (1.04%)Volume10.45 K
Updated: Mon 25 Nov, 2024 | 15:29:42
NSE
1,241.7518.05 (1.48%)
18.05 (1.48%)Volume1.76 M
Updated: Mon 25 Nov, 2024 | 15:31:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Aurobindo Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 7,351.78 | 7,219.42 | -% | 6,407.13 | -% |
| Selling/ General/ Admin Expenses Total | 989.68 | 954.97 | -% | 921.72 | -% |
| Depreciation/ Amortization | 423.27 | 417.50 | -% | 321.40 | -% |
| Other Operating Expenses Total | 1,610.22 | 1,624.48 | -% | 1,623.44 | -% |
| Total Operating Expense | 6,173.74 | 6,233.69 | -% | 5,774.12 | -% |
| Operating Income | 1,178.04 | 985.73 | -% | 633.01 | -% |
| Net Income Before Taxes | 1,262.42 | 1,075.64 | -% | 680.11 | -% |
| Net Income | 936.29 | 757.18 | -% | 491.26 | -% |
| Diluted Normalized EPS | 16.04 | 12.83 | -% | 8.38 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST